Managing Sjögren’s Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy

References

• ChristodoulouMIKapsogeorgouEKMoutsopoulosHMCharacteristics of the minor salivary gland infiltrates in Sjogren’s syndromeJ Autoimmun201034440040719889514
   PubMed Web of Science ®Google Scholar
• Garcia-CarrascoMRamos-CasalsMRosasJPrimary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patientsMedicine (Baltimore)200281427028012169882
   PubMed Web of Science ®Google Scholar
• NguyenCQPeckABUnraveling the pathophysiology of Sjogren syndrome-associated dry eye diseaseOcul Surf200971112719214349
   PubMed Web of Science ®Google Scholar
• RahimyEPitcherJDIIIPangelinanSBSpontaneous autoimmune dacryoadenitis in aged CD25KO miceAm J Pathol2010177274475320566743
   PubMed Web of Science ®Google Scholar
• PeckABNguyenCQTranscriptome analysis of the interferon-signature defining the autoimmune process of Sjogren’s syndromeScand J Immunol201276323724522703193
   PubMed Web of Science ®Google Scholar
• RobinsonCPBrayerJYamachikaSTransfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjogren’s syndromeProc Natl Acad Sci U S A19989513753875439636185
   PubMed Web of Science ®Google Scholar
• KivitySArangoMTEhrenfeldMInfection and autoimmunity in Sjogren’s syndrome: A clinical study and comprehensive reviewJ Autoimmun201451172224637076
   PubMed Web of Science ®Google Scholar
• BacmanSBerraASterin-BordaLBordaEMuscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjogren syndromeInvest Ophthalmol Vis Sci200142232132711157861
   PubMed Web of Science ®Google Scholar
• TzioufasAGWassmuthRDafniUGClinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjogren’s syndrome (pSS): a European multicentre studyAnn Rheum Dis200261539840411959762
   PubMed Web of Science ®Google Scholar
• KassanSSThomasTLMoutsopoulosHMIncreased risk of lymphoma in sicca syndromeAnn Intern Med1978896888892102228
   PubMed Web of Science ®Google Scholar
• ZulmanJJaffeRTalalNEvidence that the malignant lymphoma of Sjogren’s syndrome is a monoclonal B-cell neoplasmN Engl J Med19782992212151220309554
   PubMed Web of Science ®Google Scholar
• TheanderEJacobssonLTRelationship of Sjogren’s syndrome to other connective tissue and autoimmune disordersRheum Dis Clin North Am200834493594718984413
   PubMed Web of Science ®Google Scholar
• VitaliCBombardieriSJonssonRClassification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American–European Consensus GroupAnn Rheum Dis200261655455812006334
   PubMed Web of Science ®Google Scholar
• WhitcherJPShiboskiCHShiboskiSCA simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjogren’s Syndrome International RegistryAm J Ophthalmol2010149340541520035924
   PubMed Web of Science ®Google Scholar
• PflugfelderSCTsengSCGSanabriaOEvaluation of subjective assessments and objective diagnostic tests for diagnosing tear–film disorders known to cause ocular irritationCornea199817138569436879
   PubMed Web of Science ®Google Scholar
• MuschDCSugarAMeyerRFDemographic and predisposing factors in corneal ulcerationArch Ophthalmol198310110154515486626005
   PubMedGoogle Scholar
• de PaivaCSLindseyJLPflugfelderSCAssessing the severity of keratitis sicca with videokeratoscopic indicesOphthalmology200311061102110912799233
   PubMed Web of Science ®Google Scholar
• GotoEYagiYMatsumotoYTsubotaKImpaired functional visual acuity of dry eye patientsAm J Ophthalmol2002133218118611812420
   PubMed Web of Science ®Google Scholar
• MiljanovicBDanaRSullivanDASchaumbergDAImpact of dry eye syndrome on vision-related quality of lifeAm J Ophthalmol2007143340941517317388
   PubMed Web of Science ®Google Scholar
• LuoLLiDQDoshiAFarleyWCorralesRMPflugfelderSCExperimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surfaceInvest Ophthalmol Vis Sci200445124293430115557435
   PubMed Web of Science ®Google Scholar
• NiederkornJYSternMEPflugfelderSCDesiccating stress induces T cell-mediated Sjögren’s Syndrome-like lacrimal keratoconjunctivitisJ Immunol200617673950395716547229
   PubMed Web of Science ®Google Scholar
• ZhuXTopouzisSLiangLFStotishRLMyostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanismCytokine200426626227215183844
   PubMed Web of Science ®Google Scholar
• LopezBDUbelsJLQuantitative evaluation of the corneal epithelial barrier: effect of artificial tears and preservativesCurr Eye Res19911076456561914501
   PubMed Web of Science ®Google Scholar
• LopezBDUbelsJLArtificial tear composition and promotion of recovery of the damaged corneal epitheliumCornea19931221151208500317
   PubMed Web of Science ®Google Scholar
• JonesDTMonroyDJiZAthertonSSPflugfelderSCSjogren’s syndrome: cytokine and Epstein–Barr viral gene expression within the conjunctival epitheliumInvest Ophthalmol Vis Sci1994359349335048056525
   PubMed Web of Science ®Google Scholar
• PflugfelderSCJonesDJiZAfonsoAMonroyDAltered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren’s syndrome keratoconjunctivitis siccaCurr Eye Res199919320121110487957
   PubMed Web of Science ®Google Scholar
• SolomonADursunDLiuZXieYMacriAPflugfelderSCPro-and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye diseaseInvest Ophthalmol Vis Sci200142102283229211527941
   PubMed Web of Science ®Google Scholar
• SternMEGaoJSchwalbTAConjunctival T-cell subpopulations in Sjogren’s and non-Sjogren’s patients with dry eyeInvest Ophthalmol Vis Sci20024382609261412147592
   PubMed Web of Science ®Google Scholar
• BaudouinCLiangHBremond-GignacDCCR 4 and CCR 5 expression in conjunctival specimens as differential markers of T(H)1/T(H)2 in ocular surface disordersJ Allergy Clin Immunol2005116361461916159632
   PubMed Web of Science ®Google Scholar
• RolandoMBarabinoSMingariCMorettiSGiuffridaSCalabriaGDistribution of conjunctival HLA-DR expression and the pathogenesis of damage in early dry eyesCornea200524895195416227839
   PubMed Web of Science ®Google Scholar
• de PaivaCSVillarrealALCorralesRMDry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon–gammaInvest Ophthalmol Vis Sci20074862553256017525184
   PubMed Web of Science ®Google Scholar
• YoonKCJeongIYParkYGYangSYInterleukin-6 and tumor necrosis factor–alpha levels in tears of patients with dry eye syndromeCornea200726443143717457192
   PubMed Web of Science ®Google Scholar
• RiemensAStoyanovaERothovaAKuiperJCytokines in tear fluid of patients with ocular graft–versus–host disease after allogeneic stem cell transplantationMol Vis20121879780222509110
   PubMed Web of Science ®Google Scholar
• LamHBliedenLde PaivaCSFarleyWJSternMEPflugfelderSCTear cytokine profiles in dysfunctional tear syndromeAm J Ophthalmol2009147219820518992869
   PubMed Web of Science ®Google Scholar
• Enriquez-de-SalamancaACastellanosESternMETear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye diseaseMol Vis20101686287320508732
   PubMed Web of Science ®Google Scholar
• MassingaleMLLiXVallabhajosyulaMChenDWeiYAsbellPAAnalysis of inflammatory cytokines in the tears of dry eye patientsCornea20092891023102719724208
   PubMed Web of Science ®Google Scholar
• MrugaczMKaczmarskiMBakunowicz-LazarczykAZelazowskaBWysockaJMinarowskaAIL-8 and IFN-gamma in tear fluid of patients with cystic fibrosisJ Interferon Cytokine Res2006262717516487026
   PubMed Web of Science ®Google Scholar
• BoehmNRiechardtAIWiegandMPfeifferNGrusFHProinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarraysInvest Ophthalmol Vis Sci201152107725773021775656
   PubMed Web of Science ®Google Scholar
• CorralesRMVillarrealAFarleyWSternMELiDQPflugfelderSCStrain-related cytokine profiles on the murine ocular surface in response to desiccating stressCornea200726557958417525655
   PubMed Web of Science ®Google Scholar
• ZhangXChenWde PaivaCSInterferon-{gamma} exacerbates dry eye induced apoptosis in conjunctiva via dual apoptotic pathwaysInvest Ophthalmol Vis Sci2011529
   Web of Science ®Google Scholar
• ChenYChauhanSKSabanDRSadraiZOkanoboADanaRInterferon-{gamma}-secreting NK cells promote induction of dry eye diseaseJ Leukoc Biol201189696597221402771
   PubMed Web of Science ®Google Scholar
• ChenZMokHPflugfelderSCLiDQBarryMAImproved transduction of human corneal epithelial progenitor cells with cell-targeting adenoviral vectorsExp Eye Res200683479880616793039
   PubMed Web of Science ®Google Scholar
• KangEHLeeYJHyonJYYunPYSongYWSalivary cytokine profiles in primary Sjogren’s syndrome differ from those in non-Sjogren sicca in terms of TNF-alpha levels and Th-1/Th-2 ratiosClin Exp Rheumatol201129697097622132900
   PubMed Web of Science ®Google Scholar
• PertovaaraMAntonenJHurmeMTh2 cytokine genotypes are associated with a milder form of primary Sjogren’s syndromeAnn Rheum Dis200665566667016166103
   PubMed Web of Science ®Google Scholar
• HayashiTShimoyamaNMizunoTDestruction of salivary and LG by Th1-polarized reaction in a model of secondary Sjogren’s syndrome in lupus-prone female NZB x NZWF(1) miceInflammation201235263864621786007
   PubMed Web of Science ®Google Scholar
• OgawaNPingLZhenjunLTakadaYSugaiSInvolvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjogren’s syndromeArthritis Rheum200246102730274112384933
   PubMed Web of Science ®Google Scholar
• ViauSPasquisBMaireMANo consequences of dietary n-3 polyunsaturated fatty acid deficiency on the severity of scopolamine-induced dry eyeGraefes Arch Clin Exp Ophthalmol2011249454755721161262
   PubMed Web of Science ®Google Scholar
• JieGJiangQRuiZYifeiYExpression of interleukin-17 in autoimmune dacryoadenitis in MRL/lpr miceCurr Eye Res2010351086587120858106
   PubMed Web of Science ®Google Scholar
• PelegrinoFSVolpeEAGandhiNBLiDQPflugfelderSCde PaivaCSDeletion of interferon-gamma delays onset and severity of dacryoadenitis in CD25KO miceArthritis Res Ther2012146R23423116218
   PubMed Web of Science ®Google Scholar
• de PaivaCSHwangCSPitcherJD3rdAge-related T-cell cytokine profile parallels corneal disease severity in Sjogren’s syndrome-like keratoconjunctivitis sicca in CD25KO miceRheumatology (Oxford)201049224625820007286
   PubMed Web of Science ®Google Scholar
• KohashiMIshimaruNArakakiRHayashiYEffective treatment with oral administration of rebamipide in a mouse model of Sjogren’s syndromeArthritis Rheum200858238940018240266
   PubMed Web of Science ®Google Scholar
• KoaradaSHarutaYMitamuraMEx vivo CD(+) T-cell cytokine expression from patients with Sjogren’s syndrome following in vitro stimulation to induce proliferationRheumatology (Oxford)200645439239916287915
   PubMed Web of Science ®Google Scholar
• BrookesSMPriceEJVenablesPJMainiRNInterferon-gamma and epithelial cell activation in Sjogren’s syndromeBr J Rheumatol19953432262317728396
   PubMedGoogle Scholar
• SzodorayPGalIBarathSImmunological alterations in newly diagnosed primary Sjogren’s syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokinesScand J Rheumatol200837320521218465456
   PubMed Web of Science ®Google Scholar
• HagiwaraEPandoJIshigatsuboYKlinmanDMAltered frequency of type 1 cytokine secreting cells in the peripheral blood of patients with primary Sjogren’s syndromeJ Rheumatol199825189939458209
   PubMed Web of Science ®Google Scholar
• de PaivaCSChotikavanichSPangelinanSBIL-17 disrupts corneal barrier following desiccating stressMucosal Immunology20092324325319242409
   PubMed Web of Science ®Google Scholar
• ChauhanSKElAJEcoiffierTAutoimmunity in dry eye is due to resistance of Th17 to Treg suppressionJ Immunol200918231247125219155469
   PubMed Web of Science ®Google Scholar
• KatsifisGERekkaSMoutsopoulosNMPillemerSWahlSMSystemic and local interleukin-17 and linked cytokines associated with Sjogren’s syndrome immunopathogenesisAm J Pathol200917521167117719700754
   PubMed Web of Science ®Google Scholar
• SakaiASugawaraYKuroishiTSasanoTSugawaraSIdentification of IL-18 and Th17 cells in salivary glands of patients with Sjogren’s syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18J Immunol200818142898290618684981
   PubMed Web of Science ®Google Scholar
• NguyenCQHuMHLiYStewartCPeckABSalivary gland tissue expression of interleukin-23 and interleukin-17 in Sjogren’s syndrome: findings in humans and miceArthritis Rheum200858373474318311793
   PubMed Web of Science ®Google Scholar
• CarrenoEEnriquez-de-SalamancaATesonMCytokine and chemokine levels in tears from healthy subjectsActa Ophthalmol201088e250e25820738261
   PubMed Web of Science ®Google Scholar
• WeaverCTHattonRDManganPRHarringtonLEIL-17 family cytokines and the expanding diversity of effector T cell lineagesAnnu Rev Immunol20072582185217201677
   PubMed Web of Science ®Google Scholar
• LaFranceMWKehindeLEFullardRJMultiple cytokine analysis in human tears: an optimized procedure for cytometric bead-based assayCurr Eye Res200833752554418600485
   PubMed Web of Science ®Google Scholar
• FarrisRLTear osmolarity – a new gold standard?Adv Exp Med Biol19943504955038030524
   PubMedGoogle Scholar
• NoeckerREffects of common ophthalmic preservatives on ocular healthAdv Ther200118520521511783457
   PubMed Web of Science ®Google Scholar
• TripathiBJTripathiRCKolliSPCytotoxicity of ophthalmic preservatives on human corneal epitheliumLens Eye Toxic Res199293–43613751301792
   PubMedGoogle Scholar
• LiDQChenZSongXJFarleyWPflugfelderSCHyperosmolarity stimulates production of MMP-9, IL-1ß and TNF- by human corneal epithelial cells via a c-Jun NH2− terminal kinase pathwayInvest Ophthalmol Vis Sci200445124302431115557436
   PubMed Web of Science ®Google Scholar
• AnnesleyWHJrAugsburgerJJShakinJLTen year follow-up of photocoagulated central serous choroidopathyTrans Am Ophthalmol Soc1981793353467200672
   PubMedGoogle Scholar
• NelsonJDDrakeMMBrewerJTJrTuleyMEvaluation of a physiological tear substitute in patients with keratoconjunctivitis siccaAdv Exp Med Biol19943504534578030518
   PubMedGoogle Scholar
• LiDQLuoLChenZKimHSSongXJPflugfelderSCJNK and ERK MAP kinases mediate induction of IL-1beta, TNF-alpha and IL-8 following hyperosmolar stress in human limbal epithelial cellsExp Eye Res200682458859616202406
   PubMed Web of Science ®Google Scholar
• AfonsoAASobrinLMonroyDCSelzerMLokeshwarBPflugfelderSCTear fluid gelatinase B activity correlates with IL1-alpha concentration and fluorescein clearance in ocular rosaceaInvest Ophthalmol Vis Sci199940112506251210509643
   PubMed Web of Science ®Google Scholar
• SobrinLLiuZMonroyDCRegulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatantInvest Ophthalmol Vis Sci20004171703170910845589
   PubMed Web of Science ®Google Scholar
• PflugfelderSCFarleyWLuoLMatrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eyeAm J Pathol20051661617115632000
   PubMed Web of Science ®Google Scholar
• de PaivaCSCorralesRMVillarrealALCorticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eyeExp Eye Res200683352653516643899
   PubMed Web of Science ®Google Scholar
• ChotikavanichSde PaivaCSLi DeQProduction and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndromeInvest Ophthalmol Vis Sci20095073203320919255163
   PubMed Web of Science ®Google Scholar
• YoonKCParkCSYouICExpression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndromeInvest Ophthalmol Vis Sci201051264365019850844
   PubMed Web of Science ®Google Scholar
• CourseyTGGandhiNBVolpeEAPflugfelderSCde PaivaCSChemokine receptors CCR6 and CXCR3 are necessary for CD4(+) T cell mediated ocular surface disease in experimental dry eye diseasePLoS One2013811e7850824223818
   PubMed Web of Science ®Google Scholar
• DohlmanTHChauhanSKKodatiSThe CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye diseaseInvest Ophthalmol Vis Sci20135464081409123702781
   PubMed Web of Science ®Google Scholar
• BombardieriMBaroneFLucchesiDInducible tertiary lymphoid structures, autoimmunity, and exocrine dysfunction in a novel model of salivary gland inflammation in C57BL/6 miceJ Immunol201218973767377622942425
   PubMed Web of Science ®Google Scholar
• KramerJMEarly events in Sjogren’s Syndrome pathogenesis: The importance of innate immunity in disease initiationCytokine20146729210124656928
   PubMed Web of Science ®Google Scholar
• FavaRAKennedySMWoodSGLymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjogren’s syndromeArthritis Res Ther2011136R18222044682
   PubMed Web of Science ®Google Scholar
• BrignoleFPisellaPJGoldschildMDe SaintJMGoguelABaudouinCFlow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyesInvest Ophthalmol Vis Sci20004161356136310798650
   PubMed Web of Science ®Google Scholar
• TsubotaKFukagawaKFujiharaTRegulation of human leukocyte antigen expression in human conjunctival epitheliumInvest Ophthalmol Vis Sci199940128349888423
   PubMed Web of Science ®Google Scholar
• VersuraPProfazioVSchiaviCCamposECHyperosmolar stress upregulates HLA-DR expression in human conjunctival epithelium in dry eye patients and in vitro modelsInvest Ophthalmol Vis Sci20115285488549621498621
   PubMed Web of Science ®Google Scholar
• BaudouinCBrignoleFPisellaPJDe JeanMSGoguelAFlow cytometric analysis of the inflammatory marker HLA DR in dry eye syndrome: results from 12 months of randomized treatment with topical cyclosporin AAdv Exp Med Biol2002506Pt B76176912613989
   PubMed Web of Science ®Google Scholar
• PisellaPJBrignoleFDebbaschCFlow cytometric analysis of conjunctival epithelium in ocular rosacea and keratoconjunctivitis siccaOphthalmology2000107101841184911013183
   PubMed Web of Science ®Google Scholar
• CarsonsSA review and update of Sjogren’s syndrome: manifestations, diagnosis, and treatmentAm J Manag Care2001714 SupplS433S44311605978
   PubMed Web of Science ®Google Scholar
• PflugfelderSCHuangAJWSchuchovskiPTPereiraICTsengSCGConjunctival cytological features of primary Sjogren syndromeOphthalmology19909789859911698273
   PubMed Web of Science ®Google Scholar
• RaphaelMBellefqihSPietteJCLeHPDebrePChometteGConjunctival biopsy in Sjogren’s syndrome: correlations between histological and immunohistochemical featuresHistopathology19881321912023169687
   PubMed Web of Science ®Google Scholar
• LiSNikulinaKDeVossJSmall proline-rich protein 1B (SPRR1B) is a biomarker for squamous metaplasia in dry eye diseaseInvest Ophthalmol Vis Sci2008491344118172072
   PubMed Web of Science ®Google Scholar
• MiyataTIshiguroNYasudaYIncreased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markersBiochem Biophys Res Commun1998244145499514872
   PubMed Web of Science ®Google Scholar
• WakamatsuTHDogruMMatsumotoYEvaluation of lipid oxidative stress status in Sjogren syndrome patientsInvest Ophthalmol Vis Sci201354120121023150615
   PubMed Web of Science ®Google Scholar
• KurimotoCKawanoSTsujiGThioredoxin may exert a protective effect against tissue damage caused by oxidative stress in salivary glands of patients with Sjogren’s syndromeJ Rheumatol200734102035204317896802
   PubMed Web of Science ®Google Scholar
• SaegusaJKawanoSKoshibaMOxidative stress mediates cell surface expression of SS-A/Ro antigen on keratinocytesFree Radic Biol Med200232101006101612008116
   PubMed Web of Science ®Google Scholar
• Casciola-RosenLAAnhaltGRosenAAutoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytesJ Exp Med19941794131713307511686
   PubMed Web of Science ®Google Scholar
• JamesMJGibsonRAClelandLGDietary polyunsaturated fatty acids and inflammatory mediator productionAm J Clin Nutr2000711 Suppl343S348S10617994
   PubMed Web of Science ®Google Scholar
• EndresSGhorbaniRKelleyVEThe effect of dietary supplementation with n–3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cellsN Engl J Med198932052652712783477
   PubMed Web of Science ®Google Scholar
• JamesMJClelandLGDietary n-3 fatty acids and therapy for rheumatoid arthritisSemin Arthritis Rheum199727285979355207
   PubMed Web of Science ®Google Scholar
• KremerJMn-3 fatty acid supplements in rheumatoid arthritisAm J Clin Nutr2000711 Suppl349S351S10617995
   PubMed Web of Science ®Google Scholar
• MacsaiMSThe role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis)Trans Am Ophthalmol Soc200810633635619277245
   PubMedGoogle Scholar
• BarabinoSRolandoMCamicionePSystemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory componentCornea20032229710112605039
   PubMed Web of Science ®Google Scholar
• KangariHEftekhariMHSardariSShort-term consumption of oral omega-3 and dry eye syndromeOphthalmology2013120112191219623642375
   PubMed Web of Science ®Google Scholar
• BhargavaRKumarPKumarMMehraNMishraAA randomized controlled trial of omega-3 fatty acids in dry eye syndromeInt J Ophthalmol20136681181624392330
   PubMed Web of Science ®Google Scholar
• OlenikAJimenez-AlfaroIAlejandre-AlbaNMahillo-FernandezIA randomized, double-masked study to evaluate the effect of omega-3 fatty acids supplementation in meibomian gland dysfunctionClin Interv Aging201381133113824039409
   PubMed Web of Science ®Google Scholar
• de PaivaCSSchwartzCEGjorstrupPPflugfelderSCResolvin E1 (RX-10001) reduces corneal epithelial barrier disruption and protects against goblet cell loss in a murine model of dry eyeCornea201231111299130322257864
   PubMed Web of Science ®Google Scholar
• DarttDAHodgesRRLiDShatosMALashkariKSerhanCNConjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammationJ Immunol201118674455446621357260
   PubMed Web of Science ®Google Scholar
• RochaEMPelegrinoFSde PaivaCSVigoritoACde SouzaCAGVHD dry eyes treated with autologous serum tearsBone Marrow Transplant200025101101110310828873
   PubMed Web of Science ®Google Scholar
• TsubotaKGotoEShimmuraSShimazakiJTreatment of persistent corneal epithelial defect by autologous serum applicationOphthalmology1999106101984198910519596
   PubMed Web of Science ®Google Scholar
• TsubotaKGotoEFujitaHTreatment of dry eye by autologous serum application in Sjogren’s syndromeBr J Ophthalmol199983439039510434857
   PubMed Web of Science ®Google Scholar
• KojimaTIshidaRDogruMThe effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control studyAm J Ophthalmol2005139224224615733983
   PubMed Web of Science ®Google Scholar
• KojimaTHiguchiAGotoEMatsumotoYDogruMTsubotaKAutologous serum eye drops for the treatment of dry eye diseasesCornea200827Suppl 1S25S3018813071
   PubMed Web of Science ®Google Scholar
• UrzuaCAVasquezDHHuidobroAHernandezHAlfaroJRandomized double-blind clinical trial of autologous serum versus artificial tears in dry eye syndromeCurr Eye Res201237868468822670856
   PubMed Web of Science ®Google Scholar
• TauberJDavittWFBokoskyJEDouble-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eyeCornea200423878479215502479
   PubMed Web of Science ®Google Scholar
• OnoMTakamuraEShinozakiKTherapeutic effect of cevimeline on dry eye in patients with Sjogren’s syndrome: a randomized, double-blind clinical studyAm J Ophthalmol2004138161715234277
   PubMed Web of Science ®Google Scholar
• PetroneDCondemiJJFifeRGluckOCohenSDalginPA double-blind, randomized, placebo-controlled study of cevimeline in Sjogren’s syndrome patients with xerostomia and keratoconjunctivitis siccaArthritis Rheum200246374875411920411
   PubMed Web of Science ®Google Scholar
• VivinoFBAl-HashimiIKhanZPilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjogren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study GroupArch Intern Med199915921741819927101
   PubMedGoogle Scholar
• TsifetakiNKitsosGPaschidesCAOral pilocarpine for the treatment of ocular symptoms in patients with Sjogren’s syndrome: a randomised 12 week controlled studyAnn Rheum Dis200362121204120714644860
   PubMed Web of Science ®Google Scholar
• SolomonARosenblattMLiDDoxycycline inhibition of interleukin-1 in the corneal epitheliumAm J Ophthalmol2000130568811078862
   PubMedGoogle Scholar
• HashimotoSGonYMatsumotoKTakeshitaIMaruokaSHorieTInhalant corticosteroids inhibit hyperosmolarity-induced, and cooling and rewarming-induced interleukin-8 and RANTES production by human bronchial epithelial cellsAm J Respir Crit Care Med20001623 Pt 11075108010988133
   PubMed Web of Science ®Google Scholar
• DursunDKimMCSolomonAPflugfelderSCTreatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroidsAm J Ophthalmol2001132181311438047
   PubMed Web of Science ®Google Scholar
• LidenJRafterITrussMGustafssonJAOkretSGlucocorticoid effects on NF-kappaB binding in the transcription of the ICAM-1 geneBiochem Biophys Res Commun200027331008101410891363
   PubMed Web of Science ®Google Scholar
• AksoyMOLiXBorensteinMYiYKelsenSGEffects of topical corticosteroids on inflammatory mediator-induced eicosanoid release by human airway epithelial cellsJ Allergy Clin Immunol199910361081109110359890
   PubMed Web of Science ®Google Scholar
• BrunnerTArnoldDWasemCHerrenSFrutschiCRegulation of cell death and survival in intestinal intraepithelial lymphocytesCell Death Differ20018770671411464215
   PubMed Web of Science ®Google Scholar
• DjalilianARNagineniCNMaheshSPSmithJANussenblattRBHooksJJInhibition of inflammatory cytokine production in human corneal cells by dexamethasone, but not cyclosporinCornea200625670971417077666
   PubMed Web of Science ®Google Scholar
• PflugfelderSCMaskinSLAndersonBA randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearanceAm J Ophthalmol2004138344445715364229
   PubMed Web of Science ®Google Scholar
• MarshPPflugfelderSCTopical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndromeOphthalmology1999106481181610201607
   PubMed Web of Science ®Google Scholar
• WachtelMFreiKEhlerEFontanaAWinterhalterKGloorSMOccludin proteolysis and increased permeability in endothelial cells through tyrosine phosphatase inhibitionJ Cell Sci1999112Pt 234347435610564652
   PubMed Web of Science ®Google Scholar
• Sainz De La Maza SerraMSimon CastellviCKabbaniONonpreserved topical steroids and lacrimal punctal occlusion for severe keratoconjunctivitis siccaArch Soc Esp Oftalmol2000751175175611151264
   PubMedGoogle Scholar
• AvundukAMAvundukMCVarnellEDKaufmanHEThe comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical studyAm J Ophthalmol2003136459360214516798
   PubMed Web of Science ®Google Scholar
• ByunYJKimTIKwonSMEfficacy of combined 0.05% cyclosporine and 1% methylprednisolone treatment for chronic dry eyeCornea201231550951319730097
   PubMed Web of Science ®Google Scholar
• SheppardJDScoperSVSamudreSTopical loteprednol pretreatment reduces cyclosporine stinging in chronic dry eye diseaseJ Ocul Pharmacol Ther2011271232721133792
   PubMed Web of Science ®Google Scholar
• SolomonARosenblattMLiDQDoxycycline inhibition of interleukin-1 in the corneal epitheliumInvest Ophthalmol Vis Sci20004192544255710937565
   PubMed Web of Science ®Google Scholar
• LiYKuangKYerxaBWenQRosskothenHFischbargJRabbit conjunctival epithelium transports fluid, and P2Y2(2) receptor agonists stimulate Cl(-) and fluid secretionAm J Physiol Cell Physiol20012812C595C60211443059
   PubMed Web of Science ®Google Scholar
• MacdonaldAFeiwelMPerioral dermatitis: aetiology and treatment with tetracyclineBr J Dermatol19728743153194263288
   PubMed Web of Science ®Google Scholar
• DursunDPiniellaAMPflugfelderSCPseudokeratoconus caused by rosaceaCornea200120666866911473174
   PubMed Web of Science ®Google Scholar
• JansenTPlewigGRosacea: classification and treatmentJ R Soc Med19979031441509135612
   PubMed Web of Science ®Google Scholar
• Frucht-PeryJChayetASFeldmanSTLinSBrownSIThe effect of doxycycline on ocular rosaceaAm J Ophthalmol198910744344352522739
   PubMed Web of Science ®Google Scholar
• HoeprichPDWarshauerDMEntry of four tetracyclines into saliva and tearsAntimicrob Agents Chemother1974533303364840441
   PubMed Web of Science ®Google Scholar
• AkpekEKMerchantAPinarVFosterCSOcular rosacea: patient characteristics and follow–upOphthalmology199710411186318679373118
   PubMed Web of Science ®Google Scholar
• SeedorJAPerryHDMcNamaraTFGolubLMBuxtonDFGuthrieDSSystemic tetracycline treatment of alkali-induced corneal ulceration in rabbitsArch Ophthalmol19871052682713813962
   PubMed Web of Science ®Google Scholar
• CatonJGCiancioSGBliedenTMTreatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitisJ Periodontol200071452153210807113
   PubMed Web of Science ®Google Scholar
• LokeshwarBLMMP inhibition in prostate cancerAnn N Y Acad Sci199987827128910415736
   PubMed Web of Science ®Google Scholar
• HanemaaijerRVisserHKoolwijkPInhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cellsAdv Dent Res19981221141189972133
   PubMedGoogle Scholar
• HanemaaijerRSorsaTKonttinenYTMatrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycyclineJ Biol Chem19972725031504315099395486
   PubMed Web of Science ®Google Scholar
• QinXCorriereMAMatrisianLMGuzmanRJMatrix metalloproteinase inhibition attenuates aortic calcificationArterioscler Thromb Vasc Biol20062671510151616690876
   PubMed Web of Science ®Google Scholar
• TaCNShineWEMcCulleyJPPandyaATrattlerWNorburyJWEffects of minocycline on the ocular flora of patients with acne rosacea or seborrheic blepharitisCornea200322654554812883348
   PubMed Web of Science ®Google Scholar
• McCulleyJPDoughertyJMDeneauDGClassification of chronic blepharitisOphthalmology19828910117311806218459
   PubMed Web of Science ®Google Scholar
• ShineWEMcCulleyJPPandyaAGMinocycline effect on meibomian gland lipids in meibomianitis patientsExp Eye Res200376441742012634106
   PubMed Web of Science ®Google Scholar
• DoughertyJMMcCulleyJPSilvanyREMeyerDRThe role of tetracycline in chronic blepharitis. Inhibition of lipase production in staphylococciInvest Ophthalmol Vis Sci19913211297029751917401
   PubMed Web of Science ®Google Scholar
• GulbenkianAMyersJFriesDHamster flank organ hydrolase and lipase activityJ Invest Dermatol19807542892927430693
   PubMed Web of Science ®Google Scholar
• AronowiczJDShineWEOralDVargasJMMcCulleyJPShort term oral minocycline treatment of meibomianitisBr J Ophthalmol200690785686016613920
   PubMed Web of Science ®Google Scholar
• MatsudaSKoyasuSMechanisms of action of cyclosporineImmunopharmacology2000472–311912510878286
   PubMed Web of Science ®Google Scholar
• BramRJHungDTMartinPKSchreiberSLCrabtreeGRIdentification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular locationMol Cell Biol1993138476047697687744
   PubMed Web of Science ®Google Scholar
• AzziJRSayeghMHMallatSGCalcineurin inhibitors: 40 years later, can’t live without …J Immunol2013191125785579124319282
   PubMed Web of Science ®Google Scholar
• KaswanRLSalisburyMAWardDASpontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye dropsArch Ophthalmol19891078121012162757551
   PubMedGoogle Scholar
• GunduzKOzdemirOTopical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjogren’s syndromeActa Ophthalmol (Copenh)19947244384427825408
   PubMed Web of Science ®Google Scholar
• LaibovitzRASolchSAndrianoKO’ConnellMSilvermanMHPilot trial of cyclosporine 1% ophthalmic ointment in the treatment of keratoconjunctivitis siccaCornea19931243153238339560
   PubMed Web of Science ®Google Scholar
• StevensonDTauberJReisBLEfficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study GroupOphthalmology2000107596797410811092
   PubMed Web of Science ®Google Scholar
• SallKStevensonODMundorfTKReisBLTwo multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study GroupOphthalmology2000107463163910768324
   PubMed Web of Science ®Google Scholar
• KunertKSTisdaleASGipsonIKGoblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporineArch Ophthalmol2002120333033711879137
   PubMedGoogle Scholar
• BrignoleFPisellaPJDe SaintJMGoldschildMGoguelABaudouinCFlow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin AInvest Ophthalmol Vis Sci2001421909511133852
   PubMed Web of Science ®Google Scholar
• TurnerKPflugfelderSCJiZFeuerWJSternMReisBLInterleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsionCornea200019449249610928765
   PubMed Web of Science ®Google Scholar
• NorheimKBHarboeEGoranssonLGOmdalRInterleukin-1 inhibition and fatigue in primary Sjogren’s syndrome – a double blind, randomised clinical trialPLoS One201271e3012322253903
   PubMed Web of Science ®Google Scholar
• AmparoFDastjerdiMHOkanoboATopical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trialJAMA Ophthalmol2013131671572323599118
   PubMed Web of Science ®Google Scholar
• SembaCPTorkildsenGLLonsdaleJDA phase 2 randomized, double-masked, placebo-controlled study of a novel integrin antagonist (SAR 1118) for the treatment of dry eyeAm J Ophthalmol201215361050106022330307
   PubMed Web of Science ®Google Scholar
• LiewSHNicholsKKKlamerusKJLiJZZhangMFoulksGNTofacitinib (CP-690,550), a Janus kinase inhibitor for dry eye disease: results from a phase 1/2 trialOphthalmology201211971328133522525048
   PubMed Web of Science ®Google Scholar
• DursunDWangMMonroyDA mouse model of keratoconjunctivitis siccaInvest Ophthalmol Vis Sci200243363263811867577
   PubMed Web of Science ®Google Scholar
• de PaivaCSCorralesRMVillarrealALApical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycyclineInvest Ophthalmol Vis Sci20064772847285616799024
   PubMed Web of Science ®Google Scholar
• CorralesRMSternMEde PaivaCSWelchJLiDQPflugfelderSCDesiccating stress stimulates expression of matrix metalloproteinases by the corneal epitheliumInvest Ophthalmol Vis Sci20064783293330216877394
   PubMed Web of Science ®Google Scholar
• YoonKCde PaivaCSQiHExpression of th-1 chemokines and chemokine receptors on the ocular surface of C57BL/6 mice: effects of desiccating stressInvest Ophthalmol Vis Sci20074862561256917525185
   PubMed Web of Science ®Google Scholar
• BeardselyRMde PaivaCSPowerDFPflugfelderSCDesiccating stress decreases apical corneal epithelial cell size – modulation by the metalloproteinase inhibitor doxycyclineCornea200827893594018724157
   PubMed Web of Science ®Google Scholar
• RashidSJinYEcoiffierTBarabinoSSchaumbergDADanaMRTopical omega-3 and omega-6 fatty acids for treatment of dry eyeArch Ophthalmol2008126221922518268213
   PubMedGoogle Scholar
• GoyalSChauhanSKZhangQDanaRAmelioration of murine dry eye disease by topical antagonist to chemokine receptor 2Arch Ophthalmol2009127788288719597109
   PubMedGoogle Scholar
• EcoiffierTElAJRashidSSchaumbergDDanaRModulation of integrin alpha4beta1 (VLA-4) in dry eye diseaseArch Ophthalmol2008126121695169919064851
   PubMedGoogle Scholar
• GoyalSChauhanSKDanaRBlockade of prolymphangiogenic vascular endothelial growth factor C in dry eye diseaseArch Ophthalmol20111301848921911653
   PubMedGoogle Scholar
• LeeHSChauhanSKOkanoboANallasamyNDanaRTherapeutic efficacy of topical epigallocatechin gallate in murine dry eyeCornea201130121465147221993466
   PubMed Web of Science ®Google Scholar
• ZhangXVolpeEAGandhiNBNK cells promote Th-17 mediated corneal barrier disruption in dry eyePLoS One201275e3682222590618
   PubMed Web of Science ®Google Scholar
• StrongBFarleyWSternMEPflugfelderSCTopical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis siccaCornea2005241808515604871
   PubMed Web of Science ®Google Scholar
• de PaivaCSRainceJKMcClellanAJHomeostatic control of conjunctival mucosal goblet cells by NKT-derived IL-13Mucosal Immunol20114439740821178983
   PubMed Web of Science ®Google Scholar
• SunJWangJCyclosporine inhibits apoptosis in experimental murine xerophthalamia conjunctival epitheliumJ Huazhong Univ Sci Technolog Med Sci200626446947117120751
   PubMedGoogle Scholar
• PangelinanSBde PaivaCSSinghRTopical cyclosporine emulsion modulates immune response in experimental dry eyeInvest Ophthalmol Vis Sci200849440
   Google Scholar
• ZhangXChenWde PaivaCSDesiccating stress induces CD4(+) T-cell-mediated Sjogren’s syndrome-like corneal epithelial apoptosis via activation of the extrinsic apoptotic pathway by interferon-gammaAm J Pathol201117941807181421843497
   PubMed Web of Science ®Google Scholar
• ZhangXde PaivaCSSuZVolpeEALiDQPflugfelderSCTopical interferon-gamma neutralization prevents conjunctival goblet cell loss in experimental murine dry eyeExp Eye Res201411811712424315969
   PubMed Web of Science ®Google Scholar